PLoS ONE (Jan 2021)

Histological outcomes in HPV-screened elderly women in Denmark.

  • Gry St-Martin,
  • Petra Hall Viborg,
  • Ane Birgitte Telén Andersen,
  • Berit Andersen,
  • Jette Christensen,
  • Dorthe Ejersbo,
  • Hanne Nørgaard Heje,
  • Kirsten Marie Jochumsen,
  • Tonje Johansen,
  • Lise Grupe Larsen,
  • Elsebeth Lynge,
  • Reza Rafiolsadat Serizawa,
  • Marianne Waldstrøm

DOI
https://doi.org/10.1371/journal.pone.0246902
Journal volume & issue
Vol. 16, no. 2
p. e0246902

Abstract

Read online

IntroductionDanish women exit cervical cancer screening at age 65 years, but 23% of cervical cancer cases occur beyond this age. In addition, due to gradual implementation of cervical cancer screening, older women are underscreened by today´s standards. A one-time screening with HPV test was therefore offered to Danish women born before 1948.MethodsRegister based study reporting histology diagnoses and conizations in women found HPV positive in the one-time screening. Number and proportion of women with severe or non-severe histology results were calculated for screened and HPV-positive women by age group or region of residence. Number of women with biopsy and/or conization per case of cervical intraepithelial neoplasia (CIN) grade 2 or worse (CIN2+) or CIN3+ were also calculated by age groups and region.Results4,479 (4.1% of screened women) had positive HPV test. 94% of these had one or more additional tests. 2,785 (62%) of HPV-positive women had histology results, and conization was performed in 1,076 (24% of HPV-positive and 1% of all screened women). HPV positivity and CIN3+ detection varied little between regions, but the proportions of HPV positive women undergoing histology varied between regions from 40% to 86% and the proportion with conization from 13% to 36%. Correspondingly, the number of histologies and conizations per CIN3+ detected varied from 5.9 to 11.2 and 1.8 to 4.7, respectively. In total, 514 CIN2+ (0.47% of screened women, 11% of HPV-positive) and 337 CIN3+ (0.31% of screened women, 7.5% of HPV-positive) were diagnosed, including 37 cervical cancer cases.DiscussionHPV screening of insufficiently screened birth cohorts can potentially prevent morbidity and mortality from cervical cancer but longer follow-up is needed to see if cancer incidence declines in the screened women in the coming years. Management strategies differed among regions which influenced the proportions undergoing biopsy/conization.